Association of fibroblast growth factor 23 (FGF23) with urate metabolism in patients with chronic kidney disease (CKD): a cross-sectional study.

Association of fibroblast growth factor 23 (FGF23) with urate metabolism in patients with chronic kidney disease (CKD): a cross-sectional study. - Association of FGF23 with urate metabolism in CKD patients.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020652

Enrollment

99999

Registered

2016-01-20

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were admitted to our hospital for evaluation and education of CKD since June 2009 and gave written-informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who did not give informed consent. 2.Patients who had no available data for FGF23 and urinary parameters. 3.Patients who experienced acute exacerbation of kidney disease.

Design outcomes

Primary

Measure	Time frame
To explore factors associated with urate metabolism in CKD patients.	—

Countries

Japan

Contacts

Public ContactMASARU NAKAYAMA

National Hospital Organization Kyushu Medical Center Nephrology

nakayama.masaru.kv@mail.hosp.go.jp092-852-0700

Outcome results